Clinical Trial Update: Thalidomide in Treating Patients With Myelofibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide for primary myelofibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Primary Myelofibrosis | Phase 2 | Status: COMPLETED